Launch of inaugural SBC Open Innovation Summit
Save the date – November 15 2012
Stevenage, UK, July 6 2012 – Stevenage Bioscience Catalyst (SBC), the UK’s first open innovation bioscience campus, announces today that its inaugural Open Innovation Summit will take place on November 15 2012 in Stevenage, UK. Showcasing open innovation programmes from across the bioscience industry and at SBC, this focused event will show how open innovation is adding value to drug discovery and development.
The Summit will also feature insightful speeches from leading commentators in the field, focusing on real experiences and successful approaches to open innovation. It will be of interest to biotechnology and pharmaceutical business leaders, academic researchers, entrepreneurs, investors and government decision-makers. Registration details will be announced shortly.
‘This meeting is about making open innovation work in real life, as exemplified by the recent news that Cambridge University will be locating some research activities here in order to access drug development expertise’ said Dr Martino Picardo, CEO of Stevenage Bioscience Catalyst. ‘We are looking forward to hosting this meeting, where delegates will hear the latest results, real-life examples and good practice in this important area, and will also be updated on SBC’s open innovation initiatives in areas such as screening and biomarkers. We hope to make the Open Innovation Summit an important annual event1.’
1 Join the open innovation debate at SBC:
www.stevenagecatalyst.com
LinkedIn – Stevenage Bioscience Catalyst Open Innovation Group
twitter – @SteBioCat
